Cargando…

Hematological abnormalities in immunosuppressed patients with COVID-19: Evidence from a single center. A cross sectional study

BACKGROUND: Changes in hematological parameters in patients with COVID-19 are emerging as important features of the disease in the general population. In the present study we aimed to explore the hematological characteristics and its prevalence proportion ratio in patients with immunosuppression wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giacaman, Annesi, Henriquez, Wolfrang, Tolosa, Guillermo, Prado, Aurora, Jerez, Roxana, Reveco, Yenny, Martínez, Carlos, Baumert, Carlos, Rodríguez, Belén, Sanhueza, Basty, José Orellana, Juan, Inostroza, Jaime
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110370/ https://www.ncbi.nlm.nih.gov/pubmed/35640406 http://dx.doi.org/10.1016/j.intimp.2022.108862

Ejemplares similares

Temperature, but not excess of glycogen, regulates “in vitro” AMPK activity in muscle samples of steer carcasses
por: Strobel, Pablo, et al.
Publicado: (2021)

The role of JAK2 abnormalities in hematologic neoplasms
por: Alabdulaali, Mohammed K.
Publicado: (2009)

Hematological Abnormalities in Culture Positive Neonatal Sepsis
por: Adane, Tiruneh, et al.
Publicado: (2022)

Hematological Abnormalities in Cirrhosis: A Narrative Review
por: Lingas, Elvina C
Publicado: (2023)

Profile of hematological abnormalities of Indian HIV infected individuals
por: Dikshit, Byomakesh, et al.
Publicado: (2009)

Abnormal microRNA expression in the course of hematological malignancies
por: Szymczyk, Agnieszka, et al.
Publicado: (2018)

Hematological Abnormalities in COVID-19: A Narrative Review
por: Rahman, Asma, et al.
Publicado: (2021)

Mitochondria and Their Relationship with Common Genetic Abnormalities in Hematologic Malignancies
por: Czegle, Ibolya, et al.
Publicado: (2021)

Treatment of hidradenitis suppurativa resolves associated hematologic abnormalities
por: Morss-Walton, Peyton C., et al.
Publicado: (2022)

Immunosuppression in hematological cancer patients with Covid-19 —Uncomplicated infections but delayed viral clearance?
por: Boyd, Karen, et al.
Publicado: (2020)

Untwining Anti-Tumor and Immunosuppressive Effects of JAK Inhibitors—A Strategy for Hematological Malignancies?
por: Klein, Klara, et al.
Publicado: (2021)

Myeloid-derived suppressor cells: key immunosuppressive regulators and therapeutic targets in hematological malignancies
por: Wang, Shifen, et al.
Publicado: (2023)

Hematological abnormalities and 22q11.2 deletion syndrome
por: Rosa, Rafael Fabiano Machado, et al.
Publicado: (2011)

Hematological abnormalities in patients with malaria and typhoid in Tamale Metropolis of Ghana
por: Anabire, Nsoh Godwin, et al.
Publicado: (2018)

Sequential Treatment by Antiviral Drugs Followed by Immunosuppressive Agents for COVID-19 Patients with Hematological Malignancy
por: Seki, Masafumi, et al.
Publicado: (2022)

Hematological abnormalities in Jacobsen syndrome: cytopenia of varying severities and morphological abnormalities in peripheral blood and bone marrow
por: Yamashita, Daiki, et al.
Publicado: (2023)

Abnormal Biomarkers of Homocysteine Metabolism in Neonates with Conotruncal Heart Defects
por: Surmiak, Piotr, et al.
Publicado: (2017)

Patterns of Bone Marrow Confirmed Malignant and Non-Malignant Hematological Disorders in Patients with Abnormal Hematological Parameters in Northeast Ethiopia
por: Ebrahim, Hussen, et al.
Publicado: (2022)

Aplastic Anemia: A Common Hematological Abnormality Among Peripheral Pancytopenia
por: Biswajit, Haldar, et al.
Publicado: (2012)

Hematological parameters and peripheral blood morphologic abnormalities in children with COVID-19
por: Yarali, N., et al.
Publicado: (2020)

Adenotonsillectomy in high risk patients: Hematologic abnormalities and COVID-19 considerations
por: Ruiz, Ryan, et al.
Publicado: (2021)

Images from the Haematologica Atlas of Hematologic Cytology: abnormalities of platelet shape
por: Balduini, Carlo L., et al.
Publicado: (2022)

Pathological Effects of SARS-CoV-2 Associated with Hematological Abnormalities
por: Shama, et al.
Publicado: (2023)

The Immunosuppressant Fingolimod (FTY720) for the Treatment of Mechanical Force-Induced Abnormal Scars
por: Aoki, Masayo, et al.
Publicado: (2020)

Ionic Nanocomplexes of Hyaluronic Acid and Polyarginine to Form Solid Materials: A Green Methodology to Obtain Sponges with Biomedical Potential
por: Villamizar-Sarmiento, María Gabriela, et al.
Publicado: (2019)

Long-term immunosuppression and multiple transplants predispose systemic lupus erythematosus patients with cytopenias to hematologic malignancies
por: Lanjewar, Sonali, et al.
Publicado: (2021)

PB2048: HEMATOLOGIC RECOVERY INDUCED BY AVATROMBOPAG IN SAA REFRACTORY OR INTOLERANT TO IMMUNOSUPPRESSIVE THERAPY COMBINED WITH ELTROMBOPAG
por: Liu, Xiaoqing, et al.
Publicado: (2023)

Treatment of hemodynamically stable penetrating mediastinal gunshot wounds in chile: Comparison of 3 cases and literature review
por: Zepeda, Carlos Álvarez, et al.
Publicado: (2015)

Characteristics of hematologic malignancies with coexisting t(9;22) and inv(16) chromosomal abnormalities
por: Han, Eunhee, et al.
Publicado: (2014)

Impact of vitamin supplements on HAART related hematological abnormalities in HIV-infected patients
por: Rezaei, Esmaeil, et al.
Publicado: (2016)

Impact of severe hematological abnormalities in the outcome of hospitalized patients with influenza virus infection
por: Lalueza, A., et al.
Publicado: (2017)

Diagnostic Evaluation of Pulmonary Abnormalities in Patients with Hematologic Malignancies and Hematopoietic Cell Transplantation
por: Harris, Bianca, et al.
Publicado: (2017)

The Magnitude of Hematological Abnormalities Among COVID-19 Patients in Addis Ababa, Ethiopia
por: Araya, Shambel, et al.
Publicado: (2021)

Kikuchi-Fujimoto Disease: A Case of Febrile Cervical Lymphadenopathy With Hematological Abnormalities
por: Lee, Dong Eun, et al.
Publicado: (2023)

COVID‐19 vaccines and risks of hematological abnormalities: Nested case–control and self‐controlled case series study
por: Sing, Chor‐Wing, et al.
Publicado: (2022)

Immunosuppressive therapy in dermatology and PML
por: Sterry, Wolfram, et al.
Publicado: (2009)

New insights into leishmaniasis in the immunosuppressed
por: Akuffo, Hannah, et al.
Publicado: (2018)

Treatment of Febrile Neutropenia and Prophylaxis in Hematologic Malignancies: A Critical Review and Update
por: Villafuerte-Gutierrez, Paola, et al.
Publicado: (2014)

Biomarker Expression of Peri-Implantitis Lesions before and after Treatment: A Systematic Review
por: Moaven, Haniyeh, et al.
Publicado: (2022)

Oxaliplatin Analogues with Carboxy Derivatives of Boldine with Enhanced Antioxidant Activity
por: Mellado, Marco, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_nqregv5uv3qpcd9b3q2eddqnut